EBITDA stood at Rs. 39.9 crore and EBITDA margin for the quarter was 38.2% whereas Profit After Tax (PAT) stood at Rs. 17.5 crore translating into a PAT margin of 16.7%
The news report stating Krsnaa Diagnostics has accepted Rs 100 crores of undisclosed income is incorrect and baseless.
The tenure of contract will be upto 10 years from date of signing the contract/installation.
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies
An algorithm based testing for Fatty Liver Disease
Krsnaa Diagnostics now has its footprints in Delhi.
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
Expanding diagnostics footprint in East India
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
The company will provide free Diagnostics Service- X-ray Tele Radiology Services in District Hospitals / Sub-district Hospitals / Community Health Centers in the State of Tripura.
Subscribe To Our Newsletter & Stay Updated
